Pramlintide/insulin A21G (development name ADO09) is a combination of the amylin analogue pramlintide and an insulin analog. It is being developed by Adocia for diabetes.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.